These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 34860271)

  • 1. Effects of acids, pepsin, bile acids, and trypsin on laryngopharyngeal reflux diseases: physiopathology and therapeutic targets.
    Li Y; Xu G; Zhou B; Tang Y; Liu X; Wu Y; Wang Y; Kong J; Xu T; He C; Zhu S; Wang X; Zhang J
    Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):2743-2752. PubMed ID: 34860271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of gastroesophageal reflux disease on the clinical characteristics of patients with laryngopharyngeal reflux disease].
    Wang XY; Li JR; Zhang JH; Wang JS; Liu Z; Zhang C
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Oct; 57(10):1178-1184. PubMed ID: 36319122
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of Laryngopharyngeal Reflux and Potassium-Competitive Acid Blocker (P-CAB) on the Microbiological Comprise of the Laryngopharynx.
    Zheng X; Zheng Y; Chen T; Hou C; Zhou L; Liu C; Zheng J; Hu R
    Otolaryngol Head Neck Surg; 2024 May; 170(5):1380-1390. PubMed ID: 38385787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH Impedance and high-resolution manometry in laryngopharyngeal reflux disease high-dose proton pump inhibitor failures.
    Carroll TL; Fedore LW; Aldahlawi MM
    Laryngoscope; 2012 Nov; 122(11):2473-81. PubMed ID: 22965767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical significance of pepsin in the diagnosis of laryngopharyngeal reflux disease].
    Wang X; Chen W; Wang QP
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 May; 31(9):728-731. PubMed ID: 29871361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Laryngopharyngeal reflux disease (LPRD) in children].
    Reichel O; Saravakos P; Lorenz KJ
    Laryngorhinootologie; 2017 Jul; 96(7):485-496. PubMed ID: 28768359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation analysis between Dx-pH monitoring and proton pump inhibitor test in the diagnosis of laryngopharyngeal reflux disease].
    Chen ZL; Wu HW; Mei XW; Yin WH; Xu SY; Liu SQ; Chen YC; Wang G; Zhang CJ; Ding XL; Wu JN
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jan; 55(1):34-39. PubMed ID: 31954386
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of Pepsin and Oropharyngeal pH-Monitoring to Assess the Postoperative Outcome of Patients with Laryngopharyngeal Reflux: Results of a Pilot Trial.
    Weitzendorfer M; Pfandner R; Antoniou SA; Langsteger W; Witzel K; Emmanuel K; Koch OO
    J Laparoendosc Adv Surg Tech A; 2017 Sep; 27(9):937-943. PubMed ID: 28731842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weaning of proton pump inhibitors in patients with suspected laryngopharyngeal reflux disease.
    Lin RJ; Sridharan S; Smith LJ; Young VN; Rosen CA
    Laryngoscope; 2018 Jan; 128(1):133-137. PubMed ID: 28730666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of nonacid reflux in laryngopharyngeal reflux diseases.
    Li J; Wang J; Wu M; Zhao J; Guo H
    Eur Arch Otorhinolaryngol; 2020 Oct; 277(10):2813-2819. PubMed ID: 32390084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimum Effective Duration of Laryngopharyngeal Reflux Disease Treatment: A Prospective Study.
    Lechien JR
    Otolaryngol Head Neck Surg; 2024 Oct; 171(4):1114-1122. PubMed ID: 38961817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laryngopharyngeal reflux disease: Updated examination of mechanisms, pathophysiology, treatment, and association with gastroesophageal reflux disease.
    Cui N; Dai T; Liu Y; Wang YY; Lin JY; Zheng QF; Zhu DD; Zhu XW
    World J Gastroenterol; 2024 Apr; 30(16):2209-2219. PubMed ID: 38690022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of salivary pepsin measurement in patients with proton pump inhibitor-refractory gastroesophageal reflux disease symptoms: a prospective comparative study.
    Matsumura T; Arai M; Suzuki T; Hoppo T; Seki Y; Kasamatsu S; Ishigami H; Ishikawa K; Okimoto K; Akizue N; Maruoka D; Nakagawa T; Odaka T; Okamoto Y; Kato N
    Esophagus; 2020 Jul; 17(3):339-347. PubMed ID: 31982992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LPR: how different diagnostic tools shape the outcomes of treatment.
    Wan Y; Yan Y; Ma F; Wang L; Lu P; Maytag A; Jiang JJ
    J Voice; 2014 May; 28(3):362-8. PubMed ID: 24491501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
    de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
    World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Feasibility analysis of pepsin strip test in diagnosis of laryngopharyngeal reflux disease].
    Wang JS; Li JR; Wu MK
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 54(7):501-505. PubMed ID: 31315356
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between laryngopharyngeal reflux disease and gastroesophageal reflux disease based on synchronous esophageal and oropharyngeal Dx-pH monitoring.
    Wang L; Wang G; Li L; Fan X; Liu H; Sun Z; Han H; Li B; Ding R; Wu W
    Am J Otolaryngol; 2020; 41(3):102441. PubMed ID: 32144021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of laryngopharyngeal reflux disease: A systematic review.
    Lechien JR; Mouawad F; Barillari MR; Nacci A; Khoddami SM; Enver N; Raghunandhan SK; Calvo-Henriquez C; Eun YG; Saussez S
    World J Clin Cases; 2019 Oct; 7(19):2995-3011. PubMed ID: 31624747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pepsin and bile acids in saliva in patients with laryngopharyngeal reflux - a prospective comparative study.
    Sereg-Bahar M; Jerin A; Jansa R; Stabuc B; Hocevar-Boltezar I
    Clin Otolaryngol; 2015 Jun; 40(3):234-9. PubMed ID: 25516364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, placebo-controlled study with alginate suspension for laryngopharyngeal reflux disease.
    Tseng WH; Tseng PH; Wu JF; Hsu YC; Lee TY; Ni YH; Wang HP; Hsiao TY; Hsu WC
    Laryngoscope; 2018 Oct; 128(10):2252-2260. PubMed ID: 29399800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.